MARK E. DELANEY - 21 Oct 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
SVP & Chief Commercial Officer
Signature
Sean D. Mersten, Attorney in Fact for Mark E. Delaney
Issuer symbol
DGX
Transactions as of
21 Oct 2025
Net transactions value
+$2,836
Form type
4
Filing time
24 Oct 2025, 18:09:48 UTC
Previous filing
25 Jul 2025
Next filing
20 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DELANEY MARK E SVP & Chief Commercial Officer 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS Sean D. Mersten, Attorney in Fact for Mark E. Delaney 24 Oct 2025 0001955265

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Award $2,836 +15 +0.2% $189.08 7,530 21 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.